Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update

OBJECTIVES: Cytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our objective was to update the data in a living systematic review of the literature concerning the efficacy and toxicity of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tleyjeh, Imad M., Kashour, Zakariya, Riaz, Muhammad, Hassett, Leslie, Veiga, Viviane C., Kashour, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076756/
https://www.ncbi.nlm.nih.gov/pubmed/33915284
http://dx.doi.org/10.1016/j.cmi.2021.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076756/
https://www.ncbi.nlm.nih.gov/pubmed/33915284
http://dx.doi.org/10.1016/j.cmi.2021.04.019

Ejemplares similares